TY - JOUR
T1 - Radiotherapy for Langerhans cell histiocytosis with paraplegia
T2 - A rare oncologic emergency case report in infancy and literature review
AU - Nakashima, Kentaro
AU - Koga, Yuhki
AU - Sakai, Yasunari
AU - Takada, Hidetoshi
AU - Harimaya, Katsumi
AU - Saiji, Ohga
AU - Taguchi, Tomoaki
AU - Oda, Yoshinao
AU - Honda, Hiroshi
AU - Ohga, Shouichi
N1 - Funding Information:
We thank Dr. Keiji Matsumoto (Department of Radiology, Kyushu University Hospital, Fukuoka, Japan), Dr. Ryota Souzaki (Department of Pediatric Surgery, Kyushu University Hospital, Fukuoka, Japan), Dr. Kenichi Kohashi (Department of Pathology, Kyushu University Hospital, Fukuoka, Japan), Dr. Mamoru Muraoka and Dr. Wakako Kato (Department of Pediatrics, Kyushu University Hospital, Fukuoka, Japan) for helpful discussion and clinical management.
Publisher Copyright:
© 2018 The Japanese Society of Child Neurology
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/11
Y1 - 2018/11
N2 - Background: Langerhans cell histiocytosis (LCH) is a clonal disease with focal or disseminated lesions that may compress the surrounding tissues, including the spinal cord. Because few reports have described the spinal symptoms as the first manifestation of pediatric LCH, the long-term neurological outcomes remain unclear. Case report and literature review: We report a 21-month-old boy who presented with sudden-onset paraplegia. Imaging analyses revealed that osteolytic lesions and epidural tumors compressing the spinal cord at the T7-9 vertebrae. Twelve days after he developed leg weakness, emergency radiotherapy was started after a tumor biopsy. During the course of radiotherapy, paralysis steadily ameliorated. After we excluded infections and determined the pathological diagnosis of LCH, multi-drug chemotherapy was started. Apparent improvement in his complete paraplegia was observed after a total 15 Gy of radiotherapy and subsequent chemotherapy, leaving no neurological sequelae at 4 years of age. Through a literature search of studies published from 1980 to 2017, we found that children with LCH showed a generally favorable recovery from neurological dysfunction after the acute phase of spinal symptoms. Conclusion: This report underscores the utility of emergency radiotherapy for the neurological recovery of spinal LCH in infants. Our long-term observation further denotes the value of this treatment in terms of the intact survival with preserved motor functions and physical growth.
AB - Background: Langerhans cell histiocytosis (LCH) is a clonal disease with focal or disseminated lesions that may compress the surrounding tissues, including the spinal cord. Because few reports have described the spinal symptoms as the first manifestation of pediatric LCH, the long-term neurological outcomes remain unclear. Case report and literature review: We report a 21-month-old boy who presented with sudden-onset paraplegia. Imaging analyses revealed that osteolytic lesions and epidural tumors compressing the spinal cord at the T7-9 vertebrae. Twelve days after he developed leg weakness, emergency radiotherapy was started after a tumor biopsy. During the course of radiotherapy, paralysis steadily ameliorated. After we excluded infections and determined the pathological diagnosis of LCH, multi-drug chemotherapy was started. Apparent improvement in his complete paraplegia was observed after a total 15 Gy of radiotherapy and subsequent chemotherapy, leaving no neurological sequelae at 4 years of age. Through a literature search of studies published from 1980 to 2017, we found that children with LCH showed a generally favorable recovery from neurological dysfunction after the acute phase of spinal symptoms. Conclusion: This report underscores the utility of emergency radiotherapy for the neurological recovery of spinal LCH in infants. Our long-term observation further denotes the value of this treatment in terms of the intact survival with preserved motor functions and physical growth.
UR - http://www.scopus.com/inward/record.url?scp=85048332754&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048332754&partnerID=8YFLogxK
U2 - 10.1016/j.braindev.2018.05.016
DO - 10.1016/j.braindev.2018.05.016
M3 - Article
C2 - 29907475
AN - SCOPUS:85048332754
SN - 0387-7604
VL - 40
SP - 952
EP - 955
JO - Brain and Development
JF - Brain and Development
IS - 10
ER -